Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study. 2017

Samantha R Kaplan, and Christa Oosthuizen, and Kathryn Stinson, and Francesca Little, and Jonathan Euvrard, and Michael Schomaker, and Meg Osler, and Katherine Hilderbrand, and Andrew Boulle, and Graeme Meintjes
Yale School of Medicine, New Haven, Connecticut, United States of America.

BACKGROUND Retention in care is an essential component of meeting the UNAIDS "90-90-90" HIV treatment targets. In Khayelitsha township (population ~500,000) in Cape Town, South Africa, more than 50,000 patients have received antiretroviral therapy (ART) since the inception of this public-sector program in 2001. Disengagement from care remains an important challenge. We sought to determine the incidence of and risk factors associated with disengagement from care during 2013-2014 and outcomes for those who disengaged. RESULTS We conducted a retrospective cohort study of all patients ≥10 years of age who visited 1 of the 13 Khayelitsha ART clinics from 2013-2014 regardless of the date they initiated ART. We described the cumulative incidence of first disengagement (>180 days not attending clinic) between 1 January 2013 and 31 December 2014 using competing risks methods, enabling us to estimate disengagement incidence up to 10 years after ART initiation. We also described risk factors for disengagement based on a Cox proportional hazards model, using multiple imputation for missing data. We ascertained outcomes (death, return to care, hospital admission, other hospital contact, alive but not in care, no information) after disengagement until 30 June 2015 using province-wide health databases and the National Death Registry. Of 39,884 patients meeting our eligibility criteria, the median time on ART to 31 December 2014 was 33.6 months (IQR 12.4-63.2). Of the total study cohort, 592 (1.5%) died in the study period, 1,231 (3.1%) formally transferred out, 987 (2.5%) were silent transfers and visited another Western Cape province clinic within 180 days, 9,005 (22.6%) disengaged, and 28,069 (70.4%) remained in care. Cumulative incidence of disengagement from care was estimated to be 25.1% by 2 years and 50.3% by 5 years on ART. Key factors associated with disengagement (age, male sex, pregnancy at ART start [HR 1.58, 95% CI 1.47-1.69], most recent CD4 count) and retention (ART club membership, baseline CD4) after adjustment were similar to those found in previous studies; however, notably, the higher hazard of disengagement soon after starting ART was no longer present after adjusting for these risk factors. Of the 9,005 who disengaged, the 2 most common initial outcomes were return to ART care after 180 days (33%; n = 2,976) and being alive but not in care in the Western Cape (25%; n = 2,255). After disengagement, a total of 1,459 (16%) patients were hospitalized and 237 (3%) died. The median follow-up from date of disengagement to 30 June 2015 was 16.7 months (IQR 11-22.4). As we included only patient follow-up from 2013-2014 by design in order to maximize the generalizability of our findings to current programs, this limited our ability to more fully describe temporal trends in first disengagement. CONCLUSIONS Twenty-three percent of ART patients in the large cohort of Khayelitsha, one of the oldest public-sector ART programs in South Africa, disengaged from care at least once in a contemporary 2-year period. Fifty-eight percent of these patients either subsequently returned to care (some "silently") or remained alive without hospitalization, suggesting that many who are considered "lost" actually return to care, and that misclassification of "lost" patients is likely common in similar urban populations. A challenge to meeting ART retention targets is developing, testing, and implementing program designs to target mobile populations and retain them in lifelong care. This should be guided by risk factors for disengagement and improving interlinkage of routine information systems to better support patient care across complex care platforms.

UI MeSH Term Description Entries
D008297 Male Males
D010342 Patient Acceptance of Health Care Patients' willingness to receive health care. Acceptability of Health Care,Health Care Seeking Behavior,Acceptability of Healthcare,Acceptors of Health Care,Health Care Utilization,Nonacceptors of Health Care,Patient Acceptance of Healthcare,Care Acceptor, Health,Care Acceptors, Health,Care Nonacceptor, Health,Care Nonacceptors, Health,Health Care Acceptability,Health Care Acceptor,Health Care Acceptors,Health Care Nonacceptor,Health Care Nonacceptors,Healthcare Acceptabilities,Healthcare Acceptability,Healthcare Patient Acceptance,Healthcare Patient Acceptances,Utilization, Health Care
D012042 Registries The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers. Parish Registers,Population Register,Parish Register,Population Registers,Register, Parish,Register, Population,Registers, Parish,Registers, Population,Registry
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor

Related Publications

Samantha R Kaplan, and Christa Oosthuizen, and Kathryn Stinson, and Francesca Little, and Jonathan Euvrard, and Michael Schomaker, and Meg Osler, and Katherine Hilderbrand, and Andrew Boulle, and Graeme Meintjes
January 2023, BMC primary care,
Samantha R Kaplan, and Christa Oosthuizen, and Kathryn Stinson, and Francesca Little, and Jonathan Euvrard, and Michael Schomaker, and Meg Osler, and Katherine Hilderbrand, and Andrew Boulle, and Graeme Meintjes
April 2017, International journal of epidemiology,
Samantha R Kaplan, and Christa Oosthuizen, and Kathryn Stinson, and Francesca Little, and Jonathan Euvrard, and Michael Schomaker, and Meg Osler, and Katherine Hilderbrand, and Andrew Boulle, and Graeme Meintjes
August 2013, Tropical medicine & international health : TM & IH,
Samantha R Kaplan, and Christa Oosthuizen, and Kathryn Stinson, and Francesca Little, and Jonathan Euvrard, and Michael Schomaker, and Meg Osler, and Katherine Hilderbrand, and Andrew Boulle, and Graeme Meintjes
June 2004, AIDS (London, England),
Samantha R Kaplan, and Christa Oosthuizen, and Kathryn Stinson, and Francesca Little, and Jonathan Euvrard, and Michael Schomaker, and Meg Osler, and Katherine Hilderbrand, and Andrew Boulle, and Graeme Meintjes
April 2024, Journal of the International AIDS Society,
Samantha R Kaplan, and Christa Oosthuizen, and Kathryn Stinson, and Francesca Little, and Jonathan Euvrard, and Michael Schomaker, and Meg Osler, and Katherine Hilderbrand, and Andrew Boulle, and Graeme Meintjes
January 2014, PloS one,
Samantha R Kaplan, and Christa Oosthuizen, and Kathryn Stinson, and Francesca Little, and Jonathan Euvrard, and Michael Schomaker, and Meg Osler, and Katherine Hilderbrand, and Andrew Boulle, and Graeme Meintjes
April 2004, AIDS (London, England),
Samantha R Kaplan, and Christa Oosthuizen, and Kathryn Stinson, and Francesca Little, and Jonathan Euvrard, and Michael Schomaker, and Meg Osler, and Katherine Hilderbrand, and Andrew Boulle, and Graeme Meintjes
January 2021, PloS one,
Samantha R Kaplan, and Christa Oosthuizen, and Kathryn Stinson, and Francesca Little, and Jonathan Euvrard, and Michael Schomaker, and Meg Osler, and Katherine Hilderbrand, and Andrew Boulle, and Graeme Meintjes
September 2016, Tropical medicine & international health : TM & IH,
Samantha R Kaplan, and Christa Oosthuizen, and Kathryn Stinson, and Francesca Little, and Jonathan Euvrard, and Michael Schomaker, and Meg Osler, and Katherine Hilderbrand, and Andrew Boulle, and Graeme Meintjes
January 2017, PloS one,
Copied contents to your clipboard!